Utility of Antibiotic Treatment in Acute Non-purulent Exacerbations of COPD: a Double Blinded, Randomized, Placebo-controlled Trial of Security and Efficacy.
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Respiratory tract infections
- Focus Therapeutic Use
- Acronyms AEPOC-ATB
- 06 Feb 2018 Planned End Date changed from 1 Dec 2017 to 30 Jun 2018.
- 06 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 31 Mar 2018.
- 01 Feb 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov.